- $2.40bn
- $2.45bn
- $1.66bn
Annual income statement for Teradata, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,917 | 1,795 | 1,833 | 1,750 | 1,663 |
| Cost of Revenue | |||||
| Gross Profit | 1,186 | 1,081 | 1,115 | 1,058 | 987 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 1,686 | 1,677 | 1,647 | 1,541 | 1,458 |
| Operating Profit | 231 | 118 | 186 | 209 | 205 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 192 | 67 | 117 | 164 | 178 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 147 | 33 | 62 | 114 | 130 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 147 | 33 | 62 | 114 | 130 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 147 | 33 | 62 | 114 | 130 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.38 | 0.349 | 0.611 | 1.2 | 1.36 |